Zhiqian H. Yu, Ph.D., DABR
Department of Radiation Physics, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Radiation Physics - Patient Care, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | UT Graduate School of Biological Sciences at Houston/UT MD Anderson Cancer Center, Houston, TX, USA, PHD, Medical Physics |
| 2006 | The University of Texas at Austin, Austin, TX, USA, BS, Physics |
Postgraduate Training
| 2020-2020 | Image-Guided Radiotherapy and Chemotherapy in Gynecological Cancer: Focus on MRI Based Adaptive Brachytherapy for Cervical Cancer, Cervical Cancer Brachytherapy, ESTRO, Houston, TX |
Board Certifications
| 2016 | American Board of Radiology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, 2016 - 2019
Administrative Appointments/Responsibilities
Co-Supervisor, Residents GYN Rotation, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Chief of Physics, Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, 2018 - 2019
Other Appointments/Responsibilities
Medical Physics Residency Steering Committee Member, Thomas Jefferson University/Christiana Care, Newark, HI, 2014 - 2016
Medical Physicist, Christiana Care Health System, Newark, DE, 2013 - 2016
Institutional Committee Activities
Member, ROSI Faculty Seed Award Scientific Review Committee, 2020 - 2021
Member, New Technology Committee, 2020 - Present
Member, Radiation Oncology Research Council, 2019 - 2021
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
- Rigaud B, Anderson BM, Yu ZH, Gobeli M, Cazoulat G, Söderberg J, Samuelsson E, Lidberg D, Ward C, Taku N, Cardenas C, Rhee DJ, Venkatesan AM, Peterson CB, Court L, Svensson S, Löfman F, Klopp AH, Brock KK. Automatic segmentation using deep learning to enable online dose optimization during adaptive radiotherapy of cervical cancer. Int J Radiat Oncol Biol Phys S0360-3016(20):34484-34489, 2021. e-Pub 2020. PMID: 33181248.
- Hanania AN, Myers P, Yoder AK, Bulut A, Yu ZH, Eraj S, Bowers J, Bonnen MD, Echeverria A, Hall TR, Anderson ML, Ludwig M. Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Gynecol Oncol 152(2):353-360, 2019. e-Pub 2018. PMID: 30449720.
- Parikh AM, Coletta AM, Yu ZH, Rauch GM, Cheung JP, Court LE, Klopp AH. Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images. PLoS One 12(8):e0183515, 2017. e-Pub 2017. PMID: 28859115.
- Yu ZH, Kudchadker R, Dong L, Zhang Y, Court LE, Mourtada F, Yock A, Tucker SL, Yang J. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. J Appl Clin Med Phys 17(1):246-258, 2016. e-Pub 2016. PMID: 26894362.
- Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy 13(3):240-249, 2014. e-Pub 2013. PMID: 24188993.
- Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, 2013. e-Pub 2012. PMID: 24674314.
- Yu ZH, Lin SH, Balter P, Zhang L, Dong L. A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers. Radiother Oncol 104(1):33-38, 2012. e-Pub 2012. PMID: 22677039.
- Ikushima H, Balter P, Komaki R, Hunjun S, Bucci MK, Liao Z, McAleer MF, Yu ZH, Zhang Y, Chang JY, Dong L. Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 79(2):473-480, 2011. e-Pub 2010. PMID: 20399032.
- Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys 74(4):1283-1289, 2009. e-Pub 2009. PMID: 19427750.
- Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol 84(3):283-289, 2007. e-Pub 2007. PMID: 17716759.
Abstracts
- Ko R, Yu ZH, Prajapati S, Lee B, Albert R, Daniel A, Nguyen QN, Choi S, Msaouel P, Kudchadker R, Gomez D, Tang C. Neuromuscular Toxicity and Dose-volume Relationships Following SBRT for Bone Oligometastases: Post-hoc Analysis of Two Ongoing Clinical Trials. Inter J Radiat Onc Biol Phys, 2022. e-Pub 2022.
- Palomeque C, Basyouni S, Gee W, Wazir H, Sutton J, Hancock D, Spicer C, Dehghanpour M, Yu Z. Evaluation of Different GYN Pelvic Nodal Boost Planning Strategies to Determine the Optimal Planning and Treatment Approach. AAMD, 2022.
- Hanania A, Yoder A, Myers P, Bulut A, Yu ZH, Eraj S, Bonnen M, Echeverria A, and Ludwig M. A Single Institution Experience of Image-Guided High-Dose Rate Interstitial Brachytherapy in the Definitive Setting for Locally Advanced Cervical Cancer. Brachytherapy 17(4S):S123-S124, 2018.
- Yang K, Yu ZH, Chen H, and Mortada F. Determining VMAT Machine Limitations of An Elekta Linear Accelerator with Agility MLC for Accurate Modeling in RayStation and Robust Delivery. Med Phys 42(6,Part15):3390, 2015.
- Yu ZH, Andreou K, Yang J, Mourtada F. Auto-Segmentation Strategies for Treatment Targets and Critical Organs of H&N Cancer Patients. Med Phys 41(6,Part10):211, 2014.
Patient Reviews
CV information above last modified November 06, 2023